BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36333737)

  • 1. Loss of Brca1 and Trp53 in adult mouse mammary ductal epithelium results in development of hormone receptor-positive or hormone receptor-negative tumors, depending on inactivation of Rb family proteins.
    Szabova L; Gordon MB; Lu L; Pate N; Bassel L; Iacovelli AJ; Karim B; Homan PJ; Householder DB; Guerin TM; Burkett S; Day AM; Custer W; Weaver Ohler Z
    Breast Cancer Res; 2022 Nov; 24(1):75. PubMed ID: 36333737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 suppresses epithelial-to-mesenchymal transition and stem cell dedifferentiation during mammary and tumor development.
    Bai F; Chan HL; Scott A; Smith MD; Fan C; Herschkowitz JI; Perou CM; Livingstone AS; Robbins DJ; Capobianco AJ; Pei XH
    Cancer Res; 2014 Nov; 74(21):6161-72. PubMed ID: 25239453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-6 integrin deletion delays the formation of Brca1/p53-deficient basal-like breast tumors by restricting luminal progenitor cell expansion.
    Faraldo MM; Romagnoli M; Wallon L; Dubus P; Deugnier MA; Fre S
    Breast Cancer Res; 2024 Jun; 26(1):91. PubMed ID: 38835038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 mutation influences progesterone response in human benign mammary organoids.
    Davaadelger B; Choi MR; Singhal H; Clare SE; Khan SA; Kim JJ
    Breast Cancer Res; 2019 Nov; 21(1):124. PubMed ID: 31771627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
    Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
    Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling.
    Molyneux G; Smalley MJ
    J Mammary Gland Biol Neoplasia; 2011 Apr; 16(1):51-5. PubMed ID: 21336547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen promotes estrogen receptor negative BRCA1-deficient tumor initiation and progression.
    Wang C; Bai F; Zhang LH; Scott A; Li E; Pei XH
    Breast Cancer Res; 2018 Jul; 20(1):74. PubMed ID: 29996906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.
    Zvelebil M; Oliemuller E; Gao Q; Wansbury O; Mackay A; Kendrick H; Smalley MJ; Reis-Filho JS; Howard BA
    Breast Cancer Res; 2013 Mar; 15(2):R25. PubMed ID: 23506684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mammary-specific, long-range deletion on mouse chromosome 11 accelerates Brca1-associated mammary tumorigenesis.
    Triplett AA; Montagna C; Wagner KU
    Neoplasia; 2008 Dec; 10(12):1325-34. PubMed ID: 19048111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.
    Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX
    Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer.
    Yeo SK; Paul R; Haas M; Wang C; Guan JL
    Autophagy; 2018; 14(7):1214-1225. PubMed ID: 29938573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice.
    Yan H; Blackburn AC; McLary SC; Tao L; Roberts AL; Xavier EA; Dickinson ES; Seo JH; Arenas RB; Otis CN; Cao QJ; Lawlor RG; Osborne BA; Kittrell FS; Medina D; Jerry DJ
    Am J Pathol; 2010 Mar; 176(3):1421-32. PubMed ID: 20110418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFRβ is an essential therapeutic target for BRCA1-deficient mammary tumors.
    Bai F; Liu S; Liu X; Hollern DP; Scott A; Wang C; Zhang L; Fan C; Fu L; Perou CM; Zhu WG; Pei XH
    Breast Cancer Res; 2021 Jan; 23(1):10. PubMed ID: 33478572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
    Sun H; Zeng J; Miao Z; Lei KC; Huang C; Hu L; Su SM; Chan UI; Miao K; Zhang X; Zhang A; Guo S; Chen S; Meng Y; Deng M; Hao W; Lei H; Lin Y; Yang Z; Tang D; Wong KH; Zhang XD; Xu X; Deng CX
    Theranostics; 2021; 11(20):9967-9987. PubMed ID: 34815798
    [No Abstract]   [Full Text] [Related]  

  • 17. Cooperativity of Rb, Brca1, and p53 in malignant breast cancer evolution.
    Kumar P; Mukherjee M; Johnson JP; Patel M; Huey B; Albertson DG; Simin K
    PLoS Genet; 2012; 8(11):e1003027. PubMed ID: 23173005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice.
    Burga LN; Hu H; Juvekar A; Tung NM; Troyan SL; Hofstatter EW; Wulf GM
    Breast Cancer Res; 2011 Mar; 13(2):R30. PubMed ID: 21396117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.
    Nguyen DH; Ouyang H; Mao JH; Hlatky L; Barcellos-Hoff MH
    Cancer Res; 2014 Dec; 74(23):7149-58. PubMed ID: 25281718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.
    Clark-Knowles KV; Senterman MK; Collins O; Vanderhyden BC
    PLoS One; 2009 Dec; 4(12):e8534. PubMed ID: 20046869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.